Home » Topics » BioWorld Science

BioWorld Science
RSS

AGN-193080, a peripherally acting alpha2-agonist from Allergan

Sep. 20, 1996

Xalatan Solution now available for glaucoma

Sep. 20, 1996

First patent for IL-15

Sep. 20, 1996

Pharmacyclics signs manufacturing and supply agreement for texaphyrin products

Sep. 20, 1996

Potential DNA vaccine for B-cell lymphoma

Sep. 20, 1996

Pfizer describes anticancer application for known antidepressant

Sep. 20, 1996

New cancer therapy from The Liposome Company advances to full development

Sep. 20, 1996

Novel anticancer tyrosine kinase inhibitors from Pharmacia & Upjohn

Sep. 20, 1996

HEK4-binding protein from Amgen

Sep. 20, 1996

RPR reports novel protein farnesyltransferase inhibitors

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...